Internal Medicine, Cardiovascular Disease · Reno, NV
NPI
1467444901
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
5390 Longley Ln
Reno, NV, 89511
Phone (775) 302-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$406K
3,402 services
Medicare patients, 2024
924
Average age 76
Drug cost, 2024
$13.8M
7,932 prescriptions
Company payments, 2025
$39K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph P Stevenson was code 99214 (office e&m - established), 767 times for 532 patients. In total Joseph P Stevenson billed 3,402 services in 45 codes, and Medicare paid $406K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 767 | 532 | $95.72 | $73K |
| 93000 Electrocardiogram | Office | 471 | 415 | $10.54 | $4,963 |
| 99215 Office E&M - Established | Office | 450 | 328 | $129.71 | $58K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 336 | 83 | $2.72 | $913 |
| 93306 Echocardiography (TTE/TEE) | Office | 328 | 322 | $150.87 | $49K |
| 99205 Office E&M - New | Office | 271 | 271 | $159.64 | $43K |
| 93015 Electrocardiogram | Office | 151 | 145 | $55.95 | $8,449 |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 127 | 69 | $369.11 | $47K |
| 93298 External Electrocardiographic Monitoring | Office | 73 | 55 | $82.14 | $5,996 |
| 78431 Myocardial Perfusion Scan | Office | 70 | 69 | $1,245.40 | $87K |
| 94618 Pulmonary Function Testing | Office | 60 | 52 | $25.65 | $1,539 |
| 99213 Office E&M - Established | Office | 35 | 35 | $71.10 | $2,488 |
| 93288 External Electrocardiographic Monitoring | Office | 30 | 26 | $45.27 | $1,358 |
| 93296 External Electrocardiographic Monitoring | Office | 30 | 30 | $17.24 | $517 |
| 78452 Myocardial Perfusion Scan | Office | 29 | 29 | $349.98 | $10K |
By year: 2022 $232K for 3,987 services; 2023 $193K for 2,403 services; 2024 $406K for 3,402 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph P Stevenson prescribed most often to Medicare patients was Metoprolol Succinate, with 470 prescriptions and refills. In total Joseph P Stevenson wrote 7,932 Medicare prescriptions that cost $13.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 470 | 1,288 | 158 | $6,954 |
| Rosuvastatin Calcium Generic | 436 | 1,140 | 153 | $9,839 |
| Atorvastatin Calcium Generic | 412 | 1,200 | 151 | $4,905 |
| Eliquis Apixaban | 392 | 838 | 116 | $468K |
| Carvedilol Generic | 350 | 965 | 116 | $3,588 |
| Opsumit Macitentan | 316 | 316 | 35 | $4.0M |
| Losartan Potassium Generic | 312 | 892 | 112 | $3,328 |
| Tadalafil Generic | 309 | 357 | 37 | $297K |
| Spironolactone Generic | 277 | 728 | 102 | $3,074 |
| Ezetimibe Generic | 274 | 730 | 91 | $8,080 |
| Adempas Riociguat | 227 | 227 | 25 | $3.1M |
| Amlodipine Besylate Generic | 200 | 537 | 67 | $1,365 |
| Jardiance Empagliflozin | 200 | 429 | 69 | $242K |
| Lisinopril Generic | 199 | 586 | 72 | $1,570 |
| Bumetanide Generic | 191 | 454 | 54 | $7,356 |
Brand drugs: 1,980 claims; generic drugs: 5,952 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph P Stevenson $39K ($39K in general payments such as food, travel and fees) from 20 companies. The largest payer was United Therapeutics Corporation with $15K.
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation UTHR | 24 | $15K |
| Merck Sharp & Dohme LLC MRK | 21 | $11K |
| Actelion Pharmaceuticals US, Inc. JNJ | 18 | $9,810 |
| AngioDynamics, Inc. ANGO | 1 | $1,600 |
| Edwards Lifesciences Corporation EW | 8 | $280 |
| Novo Nordisk Inc NVO | 6 | $231 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $207 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $162 |
| BridgeBio Pharma, Inc. BBIO | 4 | $137 |
| Pfizer Inc. PFE | 4 | $91.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.